首页 | 本学科首页   官方微博 | 高级检索  
     

火把花根片联合免疫抑制方案治疗慢性移植肾肾病临床观察
引用本文:李夏玉,范永升,贺学林,何强,瞿立辉,王苏娅,黄洪锋,陈江华. 火把花根片联合免疫抑制方案治疗慢性移植肾肾病临床观察[J]. 中国中西医结合杂志, 2008, 28(9): 810-812
作者姓名:李夏玉  范永升  贺学林  何强  瞿立辉  王苏娅  黄洪锋  陈江华
作者单位:1. 浙江大学医学院附属第一医院肾脏病中心,杭州,310003
2. 浙江中医药大学
基金项目:浙江省中医药科技计划项目 
摘    要:目的 观察火把花根片联合免疫抑制方案治疗慢性移植肾病 (chronic allograft nephropathy, CAN)患者的疗效。 方法 选择符合尿蛋白≥1.0 g/24 h及血肌酐 (SCr) ≥150 (μmol/L)的CAN患者33例,分成治疗组(15例)与对照组(18例),对照组接受免疫抑制改良方案,治疗组接受火把花根片联合免疫抑制改良方案,疗程均为6个月。观察两组临床疗效,检测24 h尿蛋白、SCr及肌酐清除率(CCr)。

关 键 词:火把花根片;免疫抑制药物;慢性移植肾肾病

Clinical Observation on Treatment of Chronic Allograft Nephropathy with Colquhounia Root Tablet Combined with Immunosuppressive Protocol
LI Xia-yu,FAN Yong-sheng,HE Xue-lin. Clinical Observation on Treatment of Chronic Allograft Nephropathy with Colquhounia Root Tablet Combined with Immunosuppressive Protocol[J]. Chinese journal of integrated traditional and Western medicine, 2008, 28(9): 810-812
Authors:LI Xia-yu  FAN Yong-sheng  HE Xue-lin
Affiliation:LI Xia-yu, FAN Yong-sheng, HE Xue-lin, et al( Center of Kidney Diseases, The First Affiliated Hospital, College of Medical Sciences, Zhejiang University, Hangzhou (310003)
Abstract:Objective To observe the effects of Colquhounia root tablet (CRT) combined with immunosuppressive protocal in treating patients with chronic allografl nephropathy (CAN). Methods Thirty-three patients of CAN, with urinary protein ≥ 1.0 g/24 h and serum creatinine (SCr) ≥ 150 (μmol/L) , were assigned to two groups, the 15 in the treated group treated with CRT combining modified immunosuppressive protocol (IIP) therapy and the 18 in the control group treated with IIP alone, all for 6 months. The clinical efficiency, 24 h urinary protein and clearance of creatinine (CCr) were observed. Results The effective rate in the treated group [60% (9/ 15 cases) ]was significantly higher than that in the control group [22.0% (4/18 cases), P 〈0.05], and the lowering of 24 h urinary protein in the former was more significant than in the latter at the end of the 3rd and the 6th month of treatment (P 〈0.05) . At the end of 12-month follow-up, SCr and CCr level were stable in the treated group, while in the control group, SCr level increased and CCr level decreased significantly ( P 〈 0.05 ) , comparisons of the two indexes between the two groups at the end of the therapeutic course and follow-up study all showed significant differences ( P 〈 0.05 ). Serum ereatinine doubling to baseline were seen in 2 patients of the treated group and 7 of the control group. One patient in the treated group and 4 in the control group entered the end stage of renal disease. Conclusion Therapy with CRT combined IIP seems to be more effective in reducing urinary protein excretion in patients with CAN than that with IIP alone, and a more favorable renal function preserving effect of the former is shown by a short-term follow-up.
Keywords:Colquhounia root tablet  immunosuppressive drug  chronic allografl nephropathy
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《中国中西医结合杂志》浏览原始摘要信息
点击此处可从《中国中西医结合杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号